RPFGX | VFAIX | RPFGX / VFAIX | |
Total Expense Ratio | 0.95 | 0.09 | 1,056% |
Annual Report Gross Expense Ratio | 0.95 | 0.09 | 1,056% |
Fund Existence | 34 years | 21 years | - |
Gain YTD | -9.099 | -11.095 | 82% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 1000 | 100000 | 1% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 890M | 13.1B | 7% |
Annual Yield % from dividends | 1.48 | 1.83 | 81% |
Returns for 1 year | 5.27 | 4.26 | 124% |
Returns for 3 years | 13.97 | 14.69 | 95% |
Returns for 5 years | 75.00 | 84.56 | 89% |
Returns for 10 years | 59.16 | 115.10 | 51% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
XBI | 74.88 | 5.08 | +7.28% |
SPDR® S&P Biotech ETF | |||
MAYT | 32.04 | 2.10 | +7.01% |
AllianzIM U.S. Large Cp Buffer10 May ETF | |||
FLV | 65.46 | 3.13 | +5.02% |
American Century Foc Lrg Cp Val ETF | |||
MARW | 30.57 | 1.29 | +4.39% |
AllianzIM U.S. Large Cp Buffer20 Mar ETF | |||
IBTJ | 21.68 | -0.11 | -0.49% |
iShares iBonds Dec 2029 Term Tr ETF |